A scientific study discovered a new procedure to detect this pathology early and thus start a treatment on time.
He Alzheimer’s It affects more than 60 million people in the world. Until now, Its diagnosis required complex and expensive proceduressuch as lumbar punctures or pet tomographies. These methods limited access to an early diagnosis for many patients, especially in the field of primary care.
An investigation published in Nature Medicine presents an advance in the detection of this disease. Scientists from Spain, Sweden and Italy developed a blood test that identifies Alzheimer’s P-tau217 protein analysis. This biomarker offers a more accessible and less invasive alternative than traditional methods.
Alzheimer -.jpg
Shuttersock
Blood test with biomarker p-tau217 that changes the way to detect Alzheimer
The study included 1,767 participants with cognitive symptomswith an average age of 73 years. The tests were carried out in specialized centers and in primary care offices, using the Lumipulse platform. This Automated system is available in many hospitals and laboratorieswhich facilitates its generalized application.
The results showed that the biomarker P-TAU217 It allows to detect Alzheimer with high precision, even in its initial phases. The main advantage of this method is its ability to be implemented in the public health system, without requiring high -cost specialized equipment.
Early detection of Alzheimer’s: why can it make a difference
Dr. Eloy Rodríguez, head of neurology at the Marqués de Valdecilla-Idival University Hospital, said that This finding allows a more accessible diagnosis. The new technique Avoid invasive procedures and reduce costs Associates, which benefits a greater number of patients.
The early identification of Alzheimer’s through this blood test opens new possibilities for treatment. An early diagnosis allows to intervene in initial stages of the diseasewhen therapies can have greater impact. In addition, this advance contributes to reducing inequalities in access to diagnosis, improving perspectives for patients and their families.
Source: Ambito
I am an author and journalist who has worked in the entertainment industry for over a decade. I currently work as a news editor at a major news website, and my focus is on covering the latest trends in entertainment. I also write occasional pieces for other outlets, and have authored two books about the entertainment industry.
